Sort
48,018 grants matching “immunotherapy”
Project 1: Nanotherapies for Vemurafenib Resistant Melanoma
$506,470Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2016 · CA
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
$506,466Yuri Sykulev · Thomas Jefferson University · U01 · FY2022 · AI
Spatially precise radio-chemo-immunotherapy using antibody conjugates
$506,426Sunil J Advani · University Of California, San Diego · R01 · FY2024 · CA
Improving response durability after CAR T cell therapy for multiple myeloma
$506,376Michael C. Milone · University Of Pennsylvania · P01 · FY2023 · CA
a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease
$506,300Robert A Rissman · University Of California, San Diego · R01 · FY2021 · AG
a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease
$506,300Robert A Rissman · University Of California, San Diego · R01 · FY2020 · AG
a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease
$506,300Robert A Rissman · University Of California, San Diego · R01 · FY2018 · AG
a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease
$506,300Robert A Rissman · University Of California, San Diego · R01 · FY2019 · AG
a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease
$506,300Robert A Rissman · University Of California, San Diego · R01 · FY2017 · AG
HIFU-enhanced tumor vaccines
$506,243Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2008 · EB
CTLA-4 Inhibition and Autoimmunity in Melanoma
$506,157University Of Southern California · R01 · FY2004 · CA
Human Herpesvirus 6B in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome pathogenesis: temporal analysis of viral reactivation and immunity to elucidate cause vs effect
$506,138Eliana Lacerda · London Sch/Hygiene & Tropical Medicine · R01 · FY2023 · AI
Nanovaccine platforms to combat pancreatic cancer
$506,063Balaji Narasimhan · Iowa State University · U01 · FY2020 · CA
Tumor matrix remodeling in anti-myeloma immunity and immunotherapy
$506,049Fotios Asimakopoulos · University Of California, San Diego · R01 · FY2022 · CA
Tumor matrix remodeling in anti-myeloma immunity and immunotherapy
$506,049Fotios Asimakopoulos · University Of California, San Diego · R01 · FY2023 · CA
Cancer Pharmacology
$506,020Lorraine J Gudas · Weill Medical Coll Of Cornell Univ · T32 · FY2024 · CA
Repurposing drugs and finding new therapeutic targets for cutaneous malignancies
$505,981Natasha Hill · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
Nanocage-based systemic delivery of TGFβ trap for immunomodulation of brain neoplasms
$505,973Jung Soo Suk · Johns Hopkins University · R01 · FY2022 · NS
Structural correlates of T cell receptor signaling
$505,955Kenan Christopher Garcia · Stanford University · R01 · FY2022 · AI
Structural correlates of T cell receptor signaling
$505,955Kenan Christopher Garcia · Stanford University · R01 · FY2021 · AI
Structural correlates of T cell receptor signaling
$505,955Kenan Christopher Garcia · Stanford University · R01 · FY2024 · AI
Structural correlates of T cell receptor signaling
$505,955Kenan Christopher Garcia · Stanford University · R01 · FY2020 · AI
Structural correlates of T cell receptor signaling
$505,955Kenan Christopher Garcia · Stanford University · R01 · FY2023 · AI
Nanocage-based systemic delivery of TGFβ trap for immunomodulation of brain neoplasms
$505,850Jung Soo Suk · Johns Hopkins University · R01 · FY2023 · NS
Dissecting the NRG4 hormonal checkpoint in metabolic liver disease
$505,838Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2020 · DK